The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer. [electronic resource]
Producer: 20111207Description: 448-54 p. digitalISSN:- 1873-7560
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Carcinoma, Renal Cell -- drug therapy
- Chemotherapy, Adjuvant
- Clinical Trials, Phase II as Topic
- Disease Progression
- Disease-Free Survival
- Drug Administration Schedule
- Female
- Humans
- Indoles -- administration & dosage
- Kaplan-Meier Estimate
- Kidney Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoadjuvant Therapy
- Nephrectomy -- adverse effects
- Patient Selection
- Proportional Hazards Models
- Prospective Studies
- Protein Kinase Inhibitors -- administration & dosage
- Pyrroles -- administration & dosage
- Risk Assessment
- Risk Factors
- Sunitinib
- Survival Rate
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.